| Literature DB >> 23667163 |
Michele P Hamm1, Annabritt Chisholm, Jocelyn Shulhan, Andrea Milne, Shannon D Scott, Lisa M Given, Lisa Hartling.
Abstract
OBJECTIVE: To map the state of the existing literature evaluating the use of social media in patient and caregiver populations.Entities:
Keywords: scoping review; social media
Year: 2013 PMID: 23667163 PMCID: PMC3651969 DOI: 10.1136/bmjopen-2013-002819
Source DB: PubMed Journal: BMJ Open ISSN: 2044-6055 Impact factor: 2.692
Categorisation of social media tools
| Tool | Description | Examples |
|---|---|---|
| Collaborative projects | Enable the joint and simultaneous creation of content by many end-users | Wikis (eg, Wikipedia) |
| Blogs or microblogs | Websites that display date-stamped entries. They are usually managed by one person but provide the opportunity to interact with others through the addition of comments | Wordpress |
| Content communities | Allow for the sharing of media content between users, including text, photos, videos and presentations | BookCrossing |
| Social networking sites | Enable users to connect by creating personal information profiles that can be accessed by friends and colleagues, and by sending emails and instant messages between each other | Facebook |
| Virtual worlds | Platforms that replicate a 3D environment in which users can appear in the form of personalised avatars and interact with each other as they would in real life | Second Life |
Figure 1Flow diagram of included studies.
Description of included studies
| Variable | Total—n (%) | Excluding discussion forums—n (%) |
|---|---|---|
| Total—N | 284 | 95 |
| Continent of corresponding author | ||
| Asia | 12 (4.2) | 5 (5.3) |
| Australia | 14 (4.9) | 3 (3.2) |
| Europe | 78 (27.5) | 19 (20.0) |
| North America | 179 (63.0) | 67 (70.5) |
| Not reported | 1 (0.4) | 1 (1.1) |
| Study start date—median (range) | 2006 (1997–2011) | 2008 (2000–2011) |
| Study duration—median (range) | 5 months (1–117) | 3 months (1–117) |
| Sample size—median (range) | 124 (1–16703)* | 130 (2–16703)* |
| Publication type | ||
| Journal article | 255 (89.8) | 75 (79.0) |
| Abstract | 15 (5.3) | 8 (8.4) |
| Dissertation | 14 (4.9) | 12 (12.6) |
| Study design | ||
| Quantitative | ||
| Randomised controlled trial | 48 (16.9) | 6 (6.3) |
| Non-randomised controlled trial | 6 (2.1) | 1 (1.1) |
| Controlled before-after | 1 (0.4) | – |
| Observational | 11 (3.9) | 3 (3.2) |
| Cross-sectional | 63 (22.2) | 33 (34.7) |
| Qualitative | ||
| Case study | 1 (0.4) | – |
| Case series | 3 (1.1) | 2 (2.1) |
| Ethnography | 3 (1.1) | 2 (2.1) |
| Grounded theory | 6 (2.1) | 2 (2.1) |
| Phenomenology | 6 (2.1) | 1 (1.1) |
| Qualitative (other/not specified) | 46 (16.2) | 16 (16.8) |
| Mixed methods | 33 (11.6) | 9 (9.5) |
| Other | ||
| Content analysis | 57 (20.1) | 20 (21.1) |
| Authors’ conclusions | ||
| Positive | 186 (65.5) | 56 (59.0) |
| Neutral | 65 (22.9) | 23 (24.2) |
| Negative | 15 (5.3) | 10 (10.5) |
| Indeterminate | 18 (6.3) | 6 (6.3) |
*Excluding one study that examined >3 000 000 tweets.
Description and objectives of social media tools used (N=284)
| Objective—n (%) | ||||||
|---|---|---|---|---|---|---|
| Tool | Total—n (%) | Health literacy | Clinical decision making | Self-care | Patient safety | Others |
| Total—n (%) | 47 (16.6) | 7 (2.5) | 219 (77.1) | 19 (6.7) | 39 (13.7) | |
| Collaborative project | 6 (2.1) | 5 (83.3) | – | – | – | 1 (16.7) |
| Blog or microblog | 40 (14.1) | 11 (27.5) | – | 24 (60.0) | 4 (10.0) | 9 (22.5) |
| Content community | 16 (5.6) | 8 (50.0) | – | 5 (31.3) | 2 (12.5) | 4 (25.0) |
| Social networking site | 42 (14.8) | 10 (23.8) | 1 (2.4) | 24 (57.1) | 8 (19.1) | 9 (21.4) |
| Virtual world | 6 (2.1) | 3 (50.0) | – | 3 (50.0) | 1 (16.7) | 1 (16.7) |
| Discussion forum | 189 (66.6) | 23 (12.2) | 6 (3.2) | 166 (87.8) | 3 (1.6) | 17 (9.0) |
| Component of a complex intervention | 116 (40.9) | 16 (13.8) | 3 (2.6) | 108 (93.1) | 4 (3.5) | 3 (2.6) |
Percentages do not add up to 100 due to the possibility of multiple tools and multiple objectives per study.
Figure 2Specific social media tools described in included studies.
Outcomes measured by social media tool
| Outcomes | Total—n (%) | Excluding discussion forums—n (%) |
|---|---|---|
| Total—N | 284 | 95 |
| Patients’ knowledge | ||
| Conditions and complications | 54 (19.0) | 22 (23.2) |
| Self-care | 60 (21.1) | 17 (17.9) |
| Treatment options | 22 (7.8) | 10 (10.5) |
| Comprehension | 2 (0.7) | 1 (1.1) |
| Patients’ experience | ||
| Satisfaction | 69 (24.3) | 21 (22.1) |
| Clinician–patient communication | 39 (13.7) | 16 (16.8) |
| Peer-to-peer communication | 135 (47.5) | 44 (46.3) |
| Quality of life | 20 (7.0) | 2 (2.1) |
| Psychological well-being | 78 (27.5) | 21 (22.1) |
| Self-efficacy | 32 (11.3) | 4 (4.2) |
| Involvement and empowerment | 22 (7.8) | 6 (6.3) |
| Use of services and costs | ||
| Hospital admission rates | 4 (1.4) | 2 (2.1) |
| Emergency admission rates | 2 (0.7) | – |
| Number of visits to general practitioners | 7 (2.5) | 2 (2.1) |
| Cost effectiveness | 4 (1.4) | 3 (3.2) |
| Health behaviour and status | ||
| Self-care activities | 63 (22.2) | 15 (15.8) |
| Treatment adherence | 13 (4.6) | 1 (1.1) |
| Severity of disease or symptoms | 17 (6.0) | 4 (4.2) |
| Physical functioning | 21 (7.4) | 6 (6.3) |
| Mental functioning | 25 (8.8) | 8 (8.4) |
| Clinical indicators | 23 (8.1) | 3 (3.2) |
| Others | ||
| Attitudes and preferences | 14 (4.9) | 7 (7.4) |
| Content and accuracy | 33 (11.6) | 21 (22.1) |
| Usability | 9 (3.2) | 2 (2.1) |
| Usage and demographics | 106 (37.3) | 34 (35.8) |
Percentages do not add up to 100 due to the possibility of multiple outcomes per study.
Figure 3Word cloud representing the conditions included in the study populations. The size of each term is proportional to its representation in the review.
Social media objectives by authors’ conclusions (N=284)
| Objective—n (%) | ||||||
|---|---|---|---|---|---|---|
| Conclusions | Total—n (%) | Health literacy | Clinical decision making | Self-care | Patient safety | Others |
| Total—n (%) | 47 (16.6) | 7 (2.5) | 219 (77.1) | 19 (6.7) | 39 (13.7) | |
| Positive | 186 (65.5) | 28 (59.6) | 6 (85.7) | 149 (68.0) | 14 (73.7) | 21 (53.8) |
| Neutral | 65 (22.9) | 12 (25.5) | 1 (14.3) | 47 (21.5) | 1 (5.3) | 13 (33.3) |
| Negative | 15 (5.3) | 5 (10.6) | – | 7 (3.2) | 3 (15.8) | 3 (7.7) |
| Indeterminate | 18 (6.3) | 2 (4.3) | – | 16 (7.3) | 1 (5.3) | 2 (5.1) |
Figure 4Authors’ conclusions by statistical significance and sample size among randomised controlled trials. Each bubble represents one study and its size is proportional to the number of individuals evaluated.